Among them, actin gamma smooth muscle 2 (ACTG2) is over-expressed in HCC and is associated with poor prognosis and with a more aggressive phenotype, representing a promising therapeutic target in HCC metastasis. Here, ACTG2 is linked to hepatocellular carcinoma.